Search research articles
Contact Us
Filters
Showing results (261-270 of 284) with videos related to
Page
of 29
Sort By:
Radiation Oncology (London, England)
|
May 20, 2026
Outcome of patients with lung cancer treated with stereotactic body radiotherapy for bone oligometastases - a European multicenter cohort study
Sebastian Schäfer, Isabell Seiler, Panagiotis Balermpas, et al.
JAMA Network Open
|
January 14, 2026
Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy
Esmée L Looman, Stephanie G C Kroeze, Jana Schaule, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 8, 2017
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
S Tanadini-Lang, J Rieber, A R Filippi, et al.
The Pharmacogenomics Journal
|
June 18, 2020
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Maja Guberina, Ali Sak, Christoph Pöttgen, et al.
Thrombosis and Haemostasis
|
August 8, 2017
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents
Yukinori Harada, Jonathan Michel, Raphaela Lohaus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2018
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy
Stefan Schmidt, Annett Linge, Alex Zwanenburg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 11, 2026
A tumor DNA-Methylome derived signature of Hypoxia Identifies HPV-negative head and neck cancer patients at risk for distant metastasis after postoperative radiochemotherapy (PORT-C)
Bouchra Tawk, Gordana Halec, Katrin Rein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2016
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
Annett Linge, Steffen Löck, Volker Gudziol, et al.
Cancers
|
June 24, 2022
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
Shivaprasad Patil, Annett Linge, Hannah Hiepe, et al.
Clinical and Translational Radiation Oncology
|
March 19, 2026
Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer - results from a European multicenter cohort study
Sebastian Schäfer, Isabell Seiler, Lena Kästner, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 284) with videos related to
Sort By:
Page
of 29
Radiation Oncology (London, England)
|
May 20, 2026
Outcome of patients with lung cancer treated with stereotactic body radiotherapy for bone oligometastases - a European multicenter cohort study
Sebastian Schäfer, Isabell Seiler, Panagiotis Balermpas, et al.
JAMA Network Open
|
January 14, 2026
Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy
Esmée L Looman, Stephanie G C Kroeze, Jana Schaule, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 8, 2017
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
S Tanadini-Lang, J Rieber, A R Filippi, et al.
The Pharmacogenomics Journal
|
June 18, 2020
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Maja Guberina, Ali Sak, Christoph Pöttgen, et al.
Thrombosis and Haemostasis
|
August 8, 2017
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents
Yukinori Harada, Jonathan Michel, Raphaela Lohaus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2018
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy
Stefan Schmidt, Annett Linge, Alex Zwanenburg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 11, 2026
A tumor DNA-Methylome derived signature of Hypoxia Identifies HPV-negative head and neck cancer patients at risk for distant metastasis after postoperative radiochemotherapy (PORT-C)
Bouchra Tawk, Gordana Halec, Katrin Rein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2016
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
Annett Linge, Steffen Löck, Volker Gudziol, et al.
Cancers
|
June 24, 2022
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
Shivaprasad Patil, Annett Linge, Hannah Hiepe, et al.
Clinical and Translational Radiation Oncology
|
March 19, 2026
Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer - results from a European multicenter cohort study
Sebastian Schäfer, Isabell Seiler, Lena Kästner, et al.
Page
of 29